Guidance for Studies Evaluating the Accuracy of Biomarker-Based Nonsputum Tests to Diagnose Tuberculosis
- 8 October 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 220 (Supplement), S108-S115
- https://doi.org/10.1093/infdis/jiz356
Abstract
The World Health Organization’s (WHO) “End TB” strategy calls for development and implementation of novel tuberculosis (TB) diagnostics. Sputum-based diagnostics are challenging to implement and often less sensitive in high-priority populations. Nonsputum, biomarker-based tests may facilitate TB testing at lower levels of the healthcare system, accelerate treatment initiation, and improve outcomes. We provide guidance on the design of diagnostic accuracy studies evaluating nonsputum, biomarker-based tests within the context of WHO’s target product profile for such tests. Study designs should account for the intended use when choosing the study population, setting, and reference standards. Although adults with respiratory symptoms may be an initial target population, other high-priority populations regardless of symptoms—including people living with human immunodeficiency virus, those unable to produce sputum samples or with extrapulmonary TB, household contacts, and children—should be considered. Studies beyond diagnostic accuracy that evaluate feasibility and population-level impacts are also needed. A biomarker-based diagnostic may be critical to ending the TB epidemic, but requires appropriate validation before implementation.Keywords
This publication has 20 references indexed in Scilit:
- STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaborationBMJ Open, 2016
- Diagnostic Test Accuracy in Childhood Pulmonary Tuberculosis: A Bayesian Latent Class AnalysisAmerican Journal of Epidemiology, 2016
- Countering imprecision in precision medicineScience, 2016
- Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adultsCochrane Database of Systematic Reviews, 2016
- Laboratory Diagnosis of Extra-pulmonary Tuberculosis (EPTB) in Resource- constrained Setting: State of the Art, Challenges and the NeedJournal of Clinical and Diagnostic Research, 2015
- Diagnostic Delays and Clinical Decision Making With Centralized Xpert MTB/RIF Testing in Durban, South AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2014
- Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?The Lancet Infectious Diseases, 2014
- Tuberculosis biomarkers discovery: developments, needs, and challengesThe Lancet Infectious Diseases, 2013
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Incipient and Subclinical Tuberculosis: Defining Early Disease States in the Context of Host Immune ResponseThe Journal of Infectious Diseases, 2011